rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Robert J. More

Director

Company insider

Files Form 4 as: Director, Vir Biotechnology; Director, Tyra Biosciences; Other, Allakos; Director, Sienna Biopharmaceuticals; Director, Glaukos; 10% owner, Volcano; 10% owner, Cadence Pharmaceuticals; 10% owner, Orexigen Therapeutics.

Every Form 4 they filed

In numbers

Trades disclosed
168
Buys
5
Sells
27
Bought
$12.1M
Sold
$46.3M
Companies
12
Companies where not an officer
12
First trade
6 Feb 2006
Last trade
11 Aug 2026
Last filed
12 Aug 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
VIR Vir BiotechnologyDirector · Biotechnology · last 11 Aug 20260 buys · 7 sells
TYRA Tyra BiosciencesDirector · Biotechnology · last 28 May 20261 buy · 2 sells
AllakosOther · last 5 Mar 20210 buys · 4 sells
Sienna BiopharmaceuticalsDirector · last 30 May 20191 buy · 2 sells
GKOS GlaukosDirector · Medical Devices · last 24 Jun 20151 buy · 0 sells
Volcano10% owner · last 16 Jul 20080 buys · 7 sells
Cadence Pharmaceuticals10% owner · last 20 Feb 20080 buys · 0 sells
Orexigen Therapeutics10% owner · last 27 Nov 20071 buy · 1 sell
Novacea10% owner · last 6 Jun 20071 buy · 1 sell
Somaxon Pharmaceuticals10% owner · last 21 Dec 20060 buys · 2 sells
VNDA Vanda Pharmaceuticals10% owner · Pharmaceuticals · last 12 Dec 20060 buys · 1 sell
Iomai10% owner · last 6 Feb 20060 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
11 Aug 2026filed 12 Aug 2026VIR Vir BiotechnologyBiotechnologySEC FORM 4 Code J—8,000 at $0.00filing
11 Aug 2026filed 12 Aug 2026VIR Vir BiotechnologyBiotechnologySEC FORM 4 Code J—8,000 at $0.00filing
11 Aug 2026filed 12 Aug 2026VIR Vir BiotechnologyBiotechnologySEC FORM 4 Code J—8,000 at $0.00filing
11 Aug 2026filed 12 Aug 2026VIR Vir BiotechnologyBiotechnologySEC FORM 4 Code J—8,000 at $0.00filing
28 May 2026filed 1 Jun 2026TYRA Tyra Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—13,160 at $0.00filing
28 May 2026filed 1 Jun 2026TYRA Tyra Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—13,160 at $0.00filing
27 May 2026filed 28 May 2026VIR Vir BiotechnologyBiotechnologySEC FORM 4 Code A—8,000 at $0.00filing
27 May 2026filed 28 May 2026VIR Vir Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—16,000 at $0.00filing
27 May 2026filed 28 May 2026VIR Vir Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—16,000 at $0.00filing
27 May 2026filed 28 May 2026VIR Vir BiotechnologyBiotechnologySEC FORM 4 Code A—8,000 at $0.00filing
19 Dec 2025filed 19 Dec 2025TYRA Tyra BiosciencesBiotechnologySEC FORM 4 Sold$250K10,000 at $25.00filing
21 Nov 2025filed 25 Nov 2025TYRA Tyra BiosciencesBiotechnologySEC FORM 4 Sold$5.0M246,871 at $20.25filing
9 Jun 2025filed 9 Jun 2025VIR Vir BiotechnologyBiotechnologySEC FORM 4 Code J—14,027 at $0.00filing
9 Jun 2025filed 9 Jun 2025VIR Vir BiotechnologyBiotechnologySEC FORM 4 Code J—14,027 at $0.00filing
30 May 2025filed 2 Jun 2025VIR Vir Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—16,000 at $0.00filing
30 May 2025filed 2 Jun 2025VIR Vir BiotechnologyBiotechnologySEC FORM 4 Code A—8,000 at $0.00filing
29 May 2025filed 2 Jun 2025TYRA Tyra Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—22,200 at $0.00filing
30 May 2024filed 3 Jun 2024VIR Vir Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—16,000 at $0.00filing
30 May 2024filed 3 Jun 2024VIR Vir BiotechnologyBiotechnologySEC FORM 4 Code A—8,000 at $0.00filing
29 May 2024filed 31 May 2024TYRA Tyra Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—18,600 at $0.00filing

News

Tyra Biosciences (NASDAQ:TYRA) Stock Jumps 4.4% – Here's WhyTYRA · dailypolitical.com · 21 Oct 2026

0 headlines in the last 90 days name Robert J. More; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care12
Not placed20

Buys in green, sells in red, by the company’s sector.

Related people

RA CAPITAL MANAGEMENT, L.P.Director and 10% owner · Director and 10% owner at Tyra Biosciences, filing Form 4 there in the last year
Todd HarrisPresident and CEO · President and CEO at Tyra Biosciences, filing Form 4 there in the last year
Alan FuhrmanChief Financial Officer · Chief Financial Officer at Tyra Biosciences, filing Form 4 there in the last year
Yuliya RuebVice President, Finance (PAO) · Vice President, Finance (PAO) at Tyra Biosciences, filing Form 4 there in the last year
Rehan VerjeeDirector · Director at Tyra Biosciences, filing Form 4 there in the last year
Tomas NavratilChief Development Officer · Also traded GKOS in the last 90 days
Gilbert H. KlimanDirector · Also traded GKOS in the last 90 days
Joseph E. GilliamDirector · Also traded GKOS in the last 90 days